[ATX] YoY Quarter Result on 30-Sep-2016 [#Q2]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
29-Sep-2016
Financial Year
2017
Quarter
30-Sep-2016 [#Q2]
Profit Trend
QoQ- -24.00%
YoY- -63.09%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 0 51 657 1,182 817 15 0 -
PBT -885 -718 -2,495 -3,482 -2,135 -1,938 0 -
Tax -0 0 0 0 0 22 0 -
NP -885 -718 -2,495 -3,482 -2,135 -1,938 0 -
Tax Rate - - - - - - - -
Total Cost 885 769 3,153 4,665 2,952 1,953 0 -
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 0.00 -1,410.33 -379.58 -294.54 -261.48 -13,084.48 0.00 -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.02 -0.02 -0.11 -0.17 -0.12 -0.11 0.00 -
EPS Diluted -0.02 -0.02 -0.11 -0.17 -0.12 -0.11 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.